Related Experiment Video

Updated: Jul 4, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Evaluations of organ system development in juvenile toxicology testing

Keith Robinson1

  • 1Charles River Laboratories, Preclinical Services, 22022 Transcanadienne, Quebec H9X 3R3, Canada. keith.robinson@crl.com

Reproductive Toxicology (Elmsford, N.Y.)
|July 4, 2008
PubMed

Insights

Juvenile toxicology studies assess organ system development in young animals for drug safety. Careful study design is crucial for accurate evaluation of these complex assessments.

Area of Science:

  • Pharmacology and Toxicology
  • Developmental Biology

Background:

  • Juvenile toxicology studies are increasingly important for pharmaceutical and biotechnology products.
  • Regulatory bodies recommend a case-by-case approach for study design in this area.

Purpose of the Study:

  • To outline the scope and considerations for evaluating organ system development in juvenile toxicology studies.
  • To highlight the applicability and limitations of various functional assessments in young animals.

Main Methods:

  • Incorporation of routine toxicology assessments.
  • Evaluation of specific organ system development (nervous, cardiovascular, gastro-intestinal, pulmonary, renal, immune, skeletal, reproductive).
  • Inclusion of toxicokinetics and metabolic assessments (e.g., enzyme induction).

Main Results:

  • Functional development of multiple organ systems can be assessed in juvenile toxicology studies.
  • Reproductive and behavioral development testing is standard in rodents but presents challenges in non-rodents.
  • Toxicokinetics and hepatobiliary development can be evaluated.

Conclusions:

  • While various organ systems can be evaluated, careful consideration is needed when designing juvenile toxicology testing programs.
  • Appropriate study design is essential to ensure the validity and utility of these developmental assessments.
  • The integration of functional endpoints requires a nuanced, case-by-case approach.

More Related Videos

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System06:25

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Published on: January 12, 2024

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos07:49

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...